01 12Pfizer Canada Inc.
01 52148071
02 12189658
03 52269054
04 12467611
01 12Azithromycin Dihydrate
01 1Lyophilized in vials
02 4Powder for Oral Suspension
03 2Sustained release granules
04 5Tablet
01 12015-04-13
02 52015-04-27
03 52017-10-17
04 12024-05-18
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Brand Name : ZITHROMAX
Patent Number : 2148071
Filing Date : 1995-04-27
Strength per Unit : 250 mg / tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Brand Name : ZITHROMAX
Patent Number : 2148071
Filing Date : 1995-04-27
Strength per Unit : 100 mg / 5 ml
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Brand Name : ZITHROMAX
Patent Number : 2148071
Filing Date : 1995-04-27
Strength per Unit : 200 mg / 5 ml
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Brand Name : ZITHROMAX
Patent Number : 2148071
Filing Date : 1995-04-27
Strength per Unit : 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Brand Name : ZITHROMAX
Patent Number : 2269054
Filing Date : 1997-10-17
Strength per Unit : 250 mg / tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Brand Name : ZITHROMAX
Patent Number : 2269054
Filing Date : 1997-10-17
Strength per Unit : 100 mg / 5 ml
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Brand Name : ZITHROMAX
Patent Number : 2269054
Filing Date : 1997-10-17
Strength per Unit : 200 mg / 5 ml
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Brand Name : ZITHROMAX
Patent Number : 2148071
Filing Date : 1995-04-27
Strength per Unit : 600 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-04-27
Date Granted : 2000-10-17
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Brand Name : ZITHROMAX
Patent Number : 2269054
Filing Date : 1997-10-17
Strength per Unit : 500 mg / vial (100mg when reconstituted)
Dosage Form : Lyophilized in vials
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
Brand Name : ZITHROMAX
Patent Number : 2269054
Filing Date : 1997-10-17
Strength per Unit : 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-17
Date Granted : 2005-05-03
